Beremagene geperpavec (B‐ VEC ) for infantile dystrophic epidermolysis bullosa: Benefit of early intervention
Journal of the European Academy of Dermatology and Venereology · 2026-05 · 40 (5)
DOI: 10.1111/jdv.70028 ↗Kurz gefasst
Leserbrief in der Zeitschrift Journal of the European Academy of Dermatology and Venereology, online erschienen am 02.09.2025. Verfasst von Meropi Karakioulaki und 2 weiteren Autor:innen. Beteiligte Einrichtung: Clinic of Dermatology and Venereology, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 7 Literaturangaben.
Abstract (Originalsprache)
The data that support the findings of this study are available from the corresponding author upon reasonable request.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Clinic of Dermatology and Venereology, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
ORCID-Profile: Meropi Karakioulaki, Kilian Eyerich, Cristina Has
Zitieren
APA
Karakioulaki, M., Eyerich, K., & Has, C. (2026). Beremagene geperpavec (B‐ VEC ) for infantile dystrophic epidermolysis bullosa: Benefit of early intervention. Journal of the European Academy of Dermatology and Venereology, 40(5). https://doi.org/10.1111/jdv.70028
Vancouver
Karakioulaki M, Eyerich K, Has C. Beremagene geperpavec (B‐ VEC ) for infantile dystrophic epidermolysis bullosa: Benefit of early intervention. Journal of the European Academy of Dermatology and Venereology. 2026;40(5). doi:10.1111/jdv.70028
BibTeX
@article{Karakioulaki2026,
author = {Karakioulaki, Meropi and Eyerich, Kilian and Has, Cristina},
title = {Beremagene geperpavec (B‐ VEC ) for infantile dystrophic epidermolysis bullosa: Benefit of early intervention},
journal = {Journal of the European Academy of Dermatology and Venereology},
year = {2026},
volume = {40},
number = {5},
doi = {10.1111/jdv.70028}
}
EUVIMED